Starting at $ 115 / Month GLP-1 receptor agonist that is FDA-approved for chronic weight management Wegovy Adults with obesity (BMI 30) or overweight (BMI 27 with a weight-related condition such as hypertension, diabetes, or high cholesterol) Start todayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose
\Natural GH Stimulation: Encourages the body to release its own growth hormone in a natural, pulsed manner, which may have fewer off-target risks compared to direct GH injections
Superb Great product
Which GLP-1 is taken daily
BURN30 GLP1+ is not a prescription GLP-1 medication and should not be treated like one
FAQs: Switching from Semaglutide to Tirzepatide Can you switch from semaglutide to tirzepatide safely